Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Balchem (BCPC)

Balchem Q4 2025 net sales rise 9.8% to $263.6 million; EPS $1.21 vs $1.03

Positive Impact 3 of 5 earnings Written later

Balchem reported fourth-quarter 2025 net sales of $263.6 million, up 9.8%, and GAAP diluted EPS of $1.21 versus $1.03 a year earlier. For full-year 2025, net sales were $1.037 billion, up 8.8%, and GAAP EPS was $4.75 versus $3.93, and the company said it increased its dividend by a double-digit percentage.

Key points

  • Q4 2025 net earnings were $39.2 million, up 16.8%, and adjusted EBITDA was $67.9 million, up 8.1%.
  • Q4 adjusted EPS was $1.31 versus $1.13 a year earlier.
  • Full-year 2025 net earnings were $154.8 million, up 20.5%, and free cash flow was $173.6 million.
  • Q4 share repurchases totaled $53.6 million, and net debt was $89.4 million at December 31, 2025.

The filing

CompanyBalchem (BCPC)
Form8-K, current report
Filed with the SECFeb 20, 2026, 7:38 AM ET
Accession number0000009326-26-000004

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.